Menu

Home / For Visitors / Exhibitor Product / ALA-2000, a sustained release naltrexone injectable for alcohol use disorder or opioid use disorder

ALA-2000, a sustained release naltrexone injectable for alcohol use disorder or opioid use disorder

Category: Pharmaceutical

Exhibitor: ALAR PHARMACEUTICALS INC.

Booth No: M636

Characteristic

ALA-2000 is a long-acting injection for treating alcohol use disorder or opioid use disorder using Alar self-developed In-Relar sustained release drug delivery platform. Through steadily releasing therapeutic levels of naltrexone without dose dumping, ALA-2000 is anticipated to reduce the burden of drug administration, improving patients' medication adherence and convenience.

Other Products

Products you may be interested in

Highest Rated Products

TOP